Bozyczko-Coyne D., O-Kane T. M., Wu Z. L., Dobrzanski P., Murthy S.,
Vaught J. L. and Scott R. W. (2001) CEP-1347/KT-7515, an
inhibitor of SAPK/JNK pathway activation, promotes survival and
blocks multiple events associated with Abeta-induced cortical
neuron apoptosis. J. Neurochem. 77, 849–863.
Branton R. L. and Clarke D. J. (1999) Apoptosis in primary cultures of E14
rat ventral mesencephala: time course of dopaminergic cell death and
implications for neural transplantation. Exp. Neurol. 160, 88–98.
Brundin P., Isacson O. and Bjorklund A. (1985) Monitoring of cell
viability in suspensions of embryonic CNS tissue and its use as a
criterion for intracerebral graft survival. Brain Res. 331, 251–259.
Brundin P., Karlsson J., Emgard M., Schierle G. S., Hansson O., Petersen
A. and Castilho R. F. (2000a) Improving the survival of grafted
dopaminergic neurons: a review over current approaches. Cell
Transplant. 9, 179–195.
Brundin P., Pogarell O., Hagell P. et al. (2000b) Bilateral caudate and
putamen grafts of embryonic mesencephalic tissue treated with
lazaroids in Parkinson's disease. Brain 123, 1380–1390.
Choi W. S., Yoon S. Y., Oh T. H., Choi E. J., O'Malley K. L. and Oh Y. J.
(1999) Two distinct mechanisms are involved in 6-hydroxydopamine- and MPP+-induced dopaminergic neuronal cell death: role
of caspases, ROS, and JNK. J. Neurosci. Res. 57, 86–94.
Chun H. S., Gibson G. E., DeGiorgio L. A., Zhang H., Kidd V. J. and
Son J. H. (2001) Dopaminergic cell death induced by MPP (+),
oxidant and specific neurotoxicants shares the common molecular
mechanism. J. Neurochem. 76, 1010–1021.
Cicchetti F., Costantini L., Belizaire R., Burton W., Isacson O. and Fodor W.
(2002) Combined inhibition of apoptosis and complement improves
neural graft survival of embryonic rat and porcine mesencephalon in
the rat brain. Exp. Neurol. 177, 376–384.
Emgard M., Karlsson J., Hansson O. and Brundin P. (1999) Patterns of
cell death and dopaminergic neuron survival in intrastriatal nigral
grafts. Exp. Neurol. 160, 279–288.
Engele J. (1998) Spatial and temporal growth factor influences on developing midbrain dopaminergic neurons. J. Neurosci. 53, 405–414.
Fawcett J. W., Barker R. A. and Dunnett S. B. (1995) Dopaminergic
neuronal survival and the effects of bFGF in explant, three
dimensional and monolayer cultures of embryonic rat ventral
mesencephalon. Exp. Brain Res. 106, 275–282.
Freed C. R., Greene P. E., Breeze R. E. et al. (2001) Transplantation of
embryonic dopamine neurons for severe Parkinson's disease.
N. Engl. J. Med. 344, 710–719.
Gearan T., Castillo O. A. and Schwarzschild M. A. (2001) The parkinsonian neurotoxin, MPP+ induces phosphorylated c-Jun in
dopaminergric neurons of mesencephalic cultures. Parkinsonism
Relat. Disord. 8, 19–22.
Grasbon-Frodl E. M., Nakao N. and Brundin P. (1996) The lazaroid
U-83836E improves the survival of rat embryonic mesencephalic
tissue stored at 4 degrees C and subsequently used for cultures or
intracerebral transplantation. Brain Res. Bull. 39, 341–347.
Greene L. A. and Tischler A. S. (1976) Establishment of a noradrenergic
clonal line of rat adrenal pheochromocytoma cells which respond
to nerve growth factor. Proc. Natl Acad. Sci. USA 73, 2424–2428.
Gregersen R., Lambertsen K. and Finsen B. (2000) Microglia and
macrophages are the major source of tumor necrosis factor in
permanent middle cerebral artery occlusion in mice. J. Cereb.
Blood Flow Metab. 20, 53–65.
Hagell P. and Brundin P. (2001) Cell survival and clinical outcome
following intrastriatal transplantation in Parkinson's disease.
J. Neuropathol. Exp. Neurol. 60, 741–752.
Hall E. D. (1997) Lipid antioxidant neuroprotectants for acute and
chronic neurodegenerative disorders, in Neuroprotection in CNS
Diseases (Ba ̈r, P. R., Beal, M. F., eds), pp. 161–181. Marcel
Dekker, New York.
